|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Gene expression profiles of ERCC1, TYMS, RRM1, TUBB3 and EGFR in tumor tissue from non-small cell lung cancer patients显示文摘 | Yu Daping Li Jie Han Yi Liu Shuku Xiao Ning Li Yunsong Sun Xiaojun Liu Zhidong | 2014 | Chinese Medical Journal2014，，8： | 7 |
| 2 | Central role of myeloid MCPIP1 in protecting against LPSinduced inflammation and lung injury显示文摘Although systemic inflammatory responses attributable to infection may lead to significant lung injury,the precise molecular mechanisms leading to lung damage are poorly understood and therapeutic options remain limited.Here,we show that myeloid monocyte chemotactic protein-inducible protein 1(MCPIP1)plays a central role in protecting against LPS-induced inflammation and lung injury.Myeloid-specific MCPIP1 knockout mice developed spontaneous inflammatory syndromes,but at a late age compared to global MCPIP1 knockout mice.Moreover,mice with a myeloid-specific deletion of MCPIP1 were extremely sensitive to LPS-induced lung injury due to overproduction of proinflammatory cytokines and chemokines.We identified C/EBPβand C/EBPδ,two critical transcriptional factors that drive cytokine production and lung injury,as targets of MCPIP1 RNase.LPS administration caused MCPIP1 protein degradation in the lungs.Pharmacological inhibition of MALT1,a paracaspase that cleaves MCPIP1,by MI-2 selectively increased the MCPIP1 protein levels in macrophages and in the lungs.Meanwhile,administration of MI-2 protected mice from LPS-induced inflammation,lung injury and death.Collectively,these results indicate that myeloid MCPIP1 is central in controlling LPS-induced inflammation and lung injury.Pharmacological inhibition of MALT1 protease activity may be a good strategy to treat inflammatory diseases by enhancing MCPIP1 expression in myeloid cells. | Yong Li Xuan Huang Shengping Huang Hui He Tianhua Lei Fatma Saaoud Xiao-Qiang Yu Ari Melnick Anil Kumar Christopher J Papasian Daping Fan Mingui Fu | 2017 | Signal Transduction and Targeted Therapy2017，2，1： | 2 |
| 3 | Treatment of early stage osteonecrosis of the femoral head with autologous implantation of bone marrow-derived and cultured mesenchymal stem cells显示文摘 | Dewei Zhao Daping Cui Benjie Wang Fengde Tian Lin Guo Lei Yang Baoyi Liu Xiaobing Yu | 2011 | Bone2011，，1： | 1 |
| 4 | FCC Catalysts to Meet Demand of New Era显示文摘The CGP series FCC catalysts for manufacture of clean gasoline and propylene and the catalyst RSC-2006 for processing inferior residuum with high yield of light distillates are novel catalysts jointly developed by Qilu Catalyst Branch Company of SINOPEC Corp. and the Research Institute of Petroleum Processing (RIPP). The results of commercial application of these catalysts have revealed that they can satisfactorily meet the requirements for environmental protection, good economic benefits and capability for processing inferior FCC feed under new circumstances. | Yu Daping | 2008 | China Petroleum Processing & Petrochemical Technology2008，10，1： | 0 |
| 5 | Catalyst Innovation for Reducing Olefin Content in MGG Gasoline显示文摘为了在汽油减少石蜡内容,当保留 LPG 收益时,由 MGG (最大化的液化气体和汽油) 生产了过程, RIPP 开发了由一个更打开毛孔的矩阵和修改 Y 沸石和与金属氧化物修改的 ZRP 沸石组成的新奇催化剂。测试结果在反应变换率和产品分发由新奇催化剂提供了的可比较的反应条件下面与商业催化剂破布相比揭示了那是类似的,但是在汽油的石蜡内容获得了它在 LPG 部分与与石蜡内容的细微减小一起未改变的辛烷等级被减少。新奇催化剂的热水的稳定性比商业催化剂破布好。 | Yu Daping Qiu Zhonghong | 2010 | China Petroleum Processing & Petrochemical Technology2010，12，2： | 0 |
您所在的机构暂未开通此部分的功能，请联系管理员